Praxsyn Corporation
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PXYN research report →
About the company
Praxsyn Corporation operates as a healthcare enterprise, supplying medical professionals with specific medications and related services for their patients. The company specializes in creating non-narcotic and non-habit-forming treatments, utilizing therapeutic and preventative compounds. These come in various formats, such as transdermal creams, patches, and oral capsules, and are formulated to treat issues like pain management, erectile dysfunction, and metabolic disorders.
- CEO
- Sean Daly
- IPO
- 2010
- Employees
- 66
- HQ
- Las Vegas, IL, US
Price Chart
- Market Cap
- $6.35K
- P/E
- -0.01
- P/S
- 0.08
- P/B
- 0.00
- EV/EBITDA
- -11.85
- Div Yield
- 0.00%
- Gross Margin
- 29.39%
- Op Margin
- -240.85%
- Net Margin
- -695.52%
- ROE
- -20.21%
- ROIC
- -4.71%
- Revenue
- $81.38K · -90.06%
- Net Income
- $-566,000 · 83.81%
- EPS
- $-0.00 · 83.33%
- Op Income
- $-196,000
- FCF YoY
- 0.00%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 0.95
- Avg Volume
- 416.30K
Get TickerSpark's AI analysis on PXYN
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our PXYN coverage
Recent articles, reports, and earnings notes.
No research on PXYN yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate PXYN report →Similar companies
Peers in the same neighborhood.